2023 Nov 03
New Radiopharmaceutical Shows Antitumor Activity in Patients with Advanced Prostate Cancer
Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer. The clinical trial... Read more